Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-24-001552
Filing Date
2024-02-14
Accepted
2024-02-14 07:15:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMYLYX PHARMACEUTICALS, INC. p24-0670sc13ga.htm SC 13G/A 76464
  Complete submission text file 0000902664-24-001552.txt   77992
Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

EIN.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 43 THORNDIKE STREET CAMBRIDGE MA 02141
Business Address 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917
Amylyx Pharmaceuticals, Inc. (Subject) CIK: 0001658551 (see all company filings)

EIN.: 464600503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93265 | Film No.: 24632249
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)